Navigation Links
DATATRAK International Reports First Quarter Results for 2008
Date:5/8/2008

uct suite has been utilized in some aspect of the clinical development of 16 separate drugs and one medical device that have received regulatory approval from either the United States Food and Drug Administration or counterpart European bodies. DATATRAK International, Inc. has offices located in Cleveland, Ohio, Bonn, Germany, and Bryan, Texas. Its common stock is listed on the NASDAQ Stock Market under the ticker symbol "DATA". Visit the DATATRAK International, Inc. web site at http://www.datatrak.net .

Except for the historical information contained in this press release, the statements made in this release are forward-looking statements. These forward- looking statements are made based on management's expectations, assumptions, estimates and current beliefs concerning the operations, future results and prospects of the Company and are subject to uncertainties and factors (including those specified below) which are difficult to predict and, in many instances, are beyond the control of the Company. Factors that may cause actual results to differ materially from those in the forward-looking statements include the limited operating history on which the Company's performance can be evaluated; the ability of the Company to continue to enhance its software products to meet customer and market needs; fluctuations in the Company's quarterly results; the viability of the Company's business strategy and its early stage of development; the timing of clinical trial sponsor decisions to conduct new clinical trials or cancel or delay ongoing trials; the Company's dependence on major customers; government regulation associated with clinical trials and the approval of new drugs; the ability of the Company to compete in the emerging EDC market; losses that potentially could be incurred from breaches of contracts or loss of customer data; the inability to protect intellectual property rights or the infringement upon other's
'/>"/>

SOURCE DATATRAK International, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. DATATRAK and COResearch to Collaborate on Six Cardiac Safety Projects
2. DATATRAK(TM) Takes Clinical Trial Solutions to the Next Level With the Release of 5.0
3. Patients Treated with Risperidone Long-Acting Injection had a Significantly Longer Time to Relapse Compared to Quetiapine in International Clinical Study
4. Anadys Pharmaceuticals Presents Data on ANA598, a Non-Nucleoside Inhibitor of the HCV Polymerase, at the 21st International Conference on Antiviral Research
5. New Research for Mechanical Support Devices in Pediatrics to Be Released at International Heart and Lung Transplant Meeting
6. International ACTEMRA Rheumatoid Arthritis Study Highlighted in The Lancet
7. UMDNJ-University Hospital in Newark to Tailor Diabetes Interventions for Low-Income and Minority Groups With Grant From the International Diabetes Federation
8. Harris Corporation Teams with Cancer Treatment Services International to Advance Oncology Treatment
9. Molecular Biometrics Hires Denny Sakkas, PhD Renowned Yale Embryologist and International Thought-Leader, as Chief Scientific Officer; Opening U.S. Research Facility
10. Steps Toward Stopping Autoimmune Disease: International Consortium Identifies Genes Linked to Lupus
11. XTL Biopharmaceuticals Presents Data Regarding its Hepatitis C Virus Small Molecule Program at Hep Dart 2007 - an International Scientific Conference on Viral Hepatitis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/9/2008)...ay 9 /PRNewswire-USNewswire/ -- Osteoarthritis is ...hat affects almost 50,million people in the United...e in bone joints. The novel investigational pain m...gesic, provided significant relief,for patients wi...ith,placebo, and with fewer gastrointestinal side ...
(Date:5/9/2008)...9 /PRNewswire-USNewswire/ -- The risk of the two m...c hyperplasia (BPH), can be,reduced by changes in ...,normal weight and eating a healthy diet. Alan Kri...tion Program at Fred Hutchinson Cancer Research,Ce...uggest men need not,feel helpless against prostate...
(Date:5/9/2008)...tional Phase III Study Shows Positive Results with...TLEY, N.J., May 9 /- Roche today anno...II study showing that ACTEMRA(TM),(tocilizumab) ca...damage to,joints in patients with rheumatoid arthr...an RA treatment. The study also demonstrated that ...
(Date:5/8/2008).../- Globus Medical, Inc., the largest,...world and a recognized,leader in motion preservati...nrollment in its SECURE(R)-C Cervical Artificial D...to mimic the normal motion of the spine in,order t...ative to fusion in,the treatment of symptomatic ce...
Breaking Medicine Technology:Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 2Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 3Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 4Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 5Preventing Prostate Cancer and BPH: Prostate-Health Expert Available (National Men's Health Week Is June 9-15) 2Preventing Prostate Cancer and BPH: Prostate-Health Expert Available (National Men's Health Week Is June 9-15) 3Preventing Prostate Cancer and BPH: Prostate-Health Expert Available (National Men's Health Week Is June 9-15) 4New Study Demonstrates ACTEMRA(R) (tocilizumab) Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients 2New Study Demonstrates ACTEMRA(R) (tocilizumab) Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients 3New Study Demonstrates ACTEMRA(R) (tocilizumab) Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients 4New Study Demonstrates ACTEMRA(R) (tocilizumab) Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients 5Globus Medical Completes Enrollment Of SECURE(R)-C Cervical Artificial Disc Clinical Trial 2Menstrual blood a valuable source of multipotential stem cells 3F 3008 1Menstrual blood a valuable source of multipotential stem cells 3F 3008 2Court Throws Out Restraining Order Against SEIU 17506 1Court Throws Out Restraining Order Against SEIU 17506 2Court Throws Out Restraining Order Against SEIU 17506 3JCI table of contents 3A April 22 2008 4792 1JCI table of contents 3A April 22 2008 4792 2JCI table of contents 3A April 22 2008 4792 3JCI table of contents 3A April 22 2008 4792 4JCI table of contents 3A April 22 2008 4792 5JCI table of contents 3A April 22 2008 4792 6JCI table of contents 3A April 22 2008 4792 7JCI table of contents 3A April 22 2008 4792 8JCI table of contents 3A April 22 2008 4792 9JCI table of contents 3A April 22 2008 4792 10JCI table of contents 3A April 22 2008 4792 11JCI table of contents 3A April 22 2008 4792 12Why fruit eating bats eat dirt 3005 1Why fruit eating bats eat dirt 3005 2
...cic Cancer Studies; 11 Breast Cancer Studies; 9 Ta...PRNewswire-FirstCall/ -- Lilly,Oncology will unvei...rican Society of Clinical Oncology (ASCO) in Chica...sent important data on,GEMZAR(R) (gemcitabine HCl ...n), and enzastaurin, an investigational, oral, tar...
..., Ill.--(BUSINESS WIRE)--May 23, 2007 - Northfield...results of its,pivotal Phase III trauma trial with...rrying red blood cell substitute. The,trial was de...ent,of life-threatening red blood cell loss when t... available, not for use,interchangeably with blood...
Other Medicine Technology:Making Science Personal: Lilly Oncology to Unveil 76 Studies at,ASCO 2007 2Northfield Laboratories Reports Results of Pivotal Phase III Trauma,Study 2Northfield Laboratories Reports Results of Pivotal Phase III Trauma,Study 3Northfield Laboratories Reports Results of Pivotal Phase III Trauma,Study 4Northfield Laboratories Reports Results of Pivotal Phase III Trauma,Study 5Northfield Laboratories Reports Results of Pivotal Phase III Trauma,Study 6Northfield Laboratories Reports Results of Pivotal Phase III Trauma,Study 7Northfield Laboratories Reports Results of Pivotal Phase III Trauma,Study 8
(Date:5/12/2008)...AST LANSING, Mich., May 12 /PRNewswire-USNewswire/...nostic radiologist, was installed as,president of ...MSMS) during,the 143rd annual meeting of the MSMS ...duate of the Wayne State University School of Medi...ment of Diagnostic Radiology at Henry,Ford Hospita...
(Date:5/12/2008)...ealthPartners hosts nine physicians from Chongqing...PRNewswire-USNewswire/ -- HealthPartners,Institute...medical,delegation of Chinese physicians ever to v... physicians will observe hospital- and clinic-base...al administration and,observe clinical research me...
(Date:5/12/2008)...OSTON, May 12 /PRNewswire-FirstCall/ -- PAREXEL In... today it will be presenting at the,Robert W. Bair...s. James,Winschel, Senior Vice President and Chief...ation on PAREXEL at 10:05 a.m. EDT on Thursday, Ma...will be available through the,"Investor Relations ...
(Date:5/12/2008)...alifornia Nurses Association charged with illegall...ring Iowa Caucuses for unsolicited mailers to,work...swire/ -- The California,Nurses Association (CNA) ...otional materials to 2,000 nurses represented by t...cal 199 according to a lawsuit filed on behalf,of ...
Breaking Medicine News(10 mins):Health News:Michael A. Sandler, MD, Installed as President of Michigan State Medical Society 2Health News:First Major Chinese Medical Delegation Visits Minnesota 2Health News:PAREXEL International to Present at Robert W. Baird's 2008 Growth Stock Conference 2Health News:SEIU - New Lawsuit: CNA Violated State Law in Mass Mailings to Iowa Nurses 2Health News:SEIU - New Lawsuit: CNA Violated State Law in Mass Mailings to Iowa Nurses 3
...g to start “Hope Lodges” near major cancer hospita...s when they are getting treatment in these major c...e free accommodation to these patients who are com... treatment and these lodges could provide staying ...
... Post doc Daniel Stetson have reported in the Jour...in a different mechanism to viral DNA infection. /...aterial into DNA and RNA viruses and researchers h...cts in recognisation of these viral products in th...
... hospitals are reforming themselves to come out of... their financial management.// Patricia Hewitt, Br...l management is required and the hospital should ...fund wastage. The health secretary as said that ...
...alifornia, Los Angeles say that certain compounds ...ty formation in teeth.// The scientists found that...t inhibitors of Streptococcus mutans, the bacteria...This plant root is used to manufacture licorice ca...
Other Medicine News:
... Rigid plastic. Convenient. Single use. Kit compri...ller 2 Child; Miller 3 Medium Ad.; 1 Mac 2 Child; ...dle, Standard, 1 Nylon Carrying Case. The Lite Bla...way to take your disposable laryngoscopes anywhere...
... Stainless steel. Lamp supplied with blade. Oxygen...n any standard/conventional handle allowing you to... the potential confusion from different fitting fi...offer an easy and cost effective alternative to ex...
... Laryngoscope sets with disposable blades are an e...ime and labor by requiring no sterilization, disin... disposable blades help eliminate cross-contaminat...ate the concern for possible crosscontamination fr...
CCR Medical's Articulating Tip Laryngoscopes are the most economical units in the Industry. The articulating tip aids during difficult intubation by providing an improved view of epiglottis. Availabl
Medicine Products: